This study describes the coverage of health insurance and compares the occurrence of risk factors (RF) and protective factors of noncommunicable diseases in the population with and without health insurancesin Brazilianstate capitals. Data from the telephone survey Vigitel was analyzed. The Poisson regression model was used to estimate the prevalence ratio (PR), comparing RF among those who did or did not have a health insurance. Plan coverage was 49.1%, and the highest prevalences were in Goiania, Vitória, Florianópolis, and Belo Horizonte. Adults over 55 years of age and with higher education were more likely to have an insurance. The population with health insurance hada higher prevalence of protective factors, such as fruit and vegetable consumption (PR = 1.3 95% CI 1.2-1.3), physical activity in their free time (PR = 1.2 (95% CI: 1.2-1.3), mammographies (RP = 1.2 IC95% 1.1-1.3) and pap smears (PR = 1.1 IC95% 1.2-1.3), and lower prevalence of RFs such as smoking (RP = 0.7, 95% CI 0.6-0.8), poor health (RP = 0.8 CI95% 0.6-0.9), obesity (RP = 0.8 IC95% 0.7-0.9), consumption of meat with fat (RP = 0.9 IC95% 0.8-0.9) and whole milk (RP = 0.9 IC95% 0,8-0.9). Regardless of educational level, the population that has health insurancesgenerally has better indicators, such as healthier habits and greater coverage of preventive exams.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/1413-81232020258.32762018 | DOI Listing |
JAMA Netw Open
January 2025
Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
Importance: Nearly all Medicare Advantage (MA) plans offer dental, vision, and hearing benefits not covered by traditional Medicare (TM). However, little is known about MA enrollees' use of those benefits or how much they cost MA insurers or enrollees.
Objective: To estimate use, out-of-pocket (OOP) spending, and insurer payments for dental, hearing, and vision services among Medicare beneficiaries.
Strahlenther Onkol
January 2025
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Purpose: Recent advancements in imaging, particularly 18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT), have improved the detection of involved lymph nodes, thus influencing staging accuracy and potentially treatment outcomes. This study is a post hoc analysis of the GAZAI trial data to evaluate the impact of FDG-PET/CT versus computed tomography (CT) alone on radiation target volumes for involved-site radiotherapy (IS-RT) in early-stage follicular lymphoma (FL).
Methods: All patients in the GAZAI trial underwent pretherapeutic FDG-PET/CT examinations, which were subject to central quality control.
Osteoporos Int
January 2025
Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Cancer Epidemiol Biomarkers Prev
January 2025
Memorial Sloan Kettering Cancer Center, New York, United States.
Background: To evaluate the impact of Hispanic ethnic enclaves (EE) on the relationship between neighborhood disadvantage and overall survival (OS) in breast cancer (BCa) patients.
Methods: Data from BCa patients with stage I-IV disease diagnosed between 2005-2017 was used to analyze the effects of Area Deprivation Index (ADI) scores, a measure of neighborhood disadvantage, and census-tract level Hispanic density, a measure of EE, on OS using mixed-effects Cox regression models. The final model included the following individual-level factors (age, income, race, Hispanic/Latino origin, nativity, insurance status, and comorbidities (hypertension, diabetes, and body mass index) and clinical factors (National Comprehensive Cancer Network guideline-concordant treatment, stage, and receptor subtype).
J Allergy Clin Immunol Pract
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa.
Background: Otitis media with effusion (OME) is associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to determine the risk of undergoing OME surgery in patients with and without T2I disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!